| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comprehensive assessment of patient experience and disease-related awareness in multiple sclerosis: A questionnaire-based nation-wide survey in Turkey
|
Demir, Serkan
|
|
|
52 |
C |
p.
|
artikel
|
| 2 |
A mindfulness group intervention in newly diagnosed persons with multiple sclerosis: A pilot study
|
Morrow, Sarah A.
|
|
|
52 |
C |
p.
|
artikel
|
| 3 |
A mixed-methods study of cognitive performance in persons with multiple sclerosis: Association between neuropsychological test performance and interviews about daily cognitive functioning
|
Akbar, Nadine
|
|
|
52 |
C |
p.
|
artikel
|
| 4 |
Anti-CD20 antibody therapy and risk of infection in patients with demyelinating diseases
|
Oksbjerg, N.R.
|
|
|
52 |
C |
p.
|
artikel
|
| 5 |
A real-world single-centre analysis of alemtuzumab and cladribine for multiple sclerosis
|
Bose, Gauruv
|
|
|
52 |
C |
p.
|
artikel
|
| 6 |
Association of Epstein-Barr virus latently expressed genes with multiple sclerosis
|
Varvatsi, Despina
|
|
|
52 |
C |
p.
|
artikel
|
| 7 |
Attenuation of antibody response to SARS-CoV-2 infection in patients with multiple sclerosis on ocrelizumab: A case-control study
|
Conte, William L.
|
|
|
52 |
C |
p.
|
artikel
|
| 8 |
Bilateral optic neuritis in a 15-month-old girl from neuromyelitis optica spectrum disorder: The youngest reported case in the literature
|
Wadley, Sean
|
|
|
52 |
C |
p.
|
artikel
|
| 9 |
Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study
|
Barzegar, Mahdi
|
|
|
52 |
C |
p.
|
artikel
|
| 10 |
Challenges of switching towards anti-CD20 monoclonal antibodies in RR-MS: A monocentric study
|
Boudot de la Motte, Marine
|
|
|
52 |
C |
p.
|
artikel
|
| 11 |
Clinical experience of plasmapheresis for neuromyelitis optica patients in Mexico
|
Gómez-Figueroa, Enrique
|
|
|
52 |
C |
p.
|
artikel
|
| 12 |
Conus involvement and leptomeningeal enhancement in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: A case report
|
Safadi, Amy Li
|
|
|
52 |
C |
p.
|
artikel
|
| 13 |
COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies
|
Garjani, Afagh
|
|
|
52 |
C |
p.
|
artikel
|
| 14 |
COVID-19 vaccines in multiple sclerosis treated with cladribine or ocrelizumab
|
Buttari, Fabio
|
|
|
52 |
C |
p.
|
artikel
|
| 15 |
Cross-sectional analysis of peripheral blood mononuclear cells in lymphopenic and non-lymphopenic relapsing-remitting multiple sclerosis patients treated with dimethyl fumarate.
|
Lee, Chieh-Hsin
|
|
|
52 |
C |
p.
|
artikel
|
| 16 |
Cytotoxic profile of CD3+CD20+ T cells in progressive multiple sclerosis
|
Boldrini, Vinícius O.
|
|
|
52 |
C |
p.
|
artikel
|
| 17 |
Depression and anxiety in multiple sclerosis patients: The role of genetic variability of interleukin 1β
|
Ferreira, Ana Marta
|
|
|
52 |
C |
p.
|
artikel
|
| 18 |
DPPX autoimmune encephalitis: A short report on two patients presenting with classic features of this rare but treatable disease
|
Mbonde, Amir A.
|
|
|
52 |
C |
p.
|
artikel
|
| 19 |
Effects of hippotherapy on postural balance, functional mobility, self-perceived fatigue, and quality of life in people with relapsing-remitting multiple sclerosis: Secondary results of an exploratory clinical trial
|
Moraes, Andréa Gomes
|
|
|
52 |
C |
p.
|
artikel
|
| 20 |
Efficacy and safety of ocrelizumab vs interferon beta-1a in participants of African descent with relapsing multiple sclerosis in the Phase III OPERA I and OPERA II studies
|
Cree, Bruce A.C.
|
|
|
52 |
C |
p.
|
artikel
|
| 21 |
Elevated chemokines and cytokines for eosinophils in neuromyelitis optica spectrum disorders
|
Du, Li
|
|
|
52 |
C |
p.
|
artikel
|
| 22 |
Enhanced frontoparietal connectivity in multiple sclerosis patients and healthy controls in response to an intensive computerized training focused on working memory
|
Aguirre, Naiara
|
|
|
52 |
C |
p.
|
artikel
|
| 23 |
Epidemiology of multiple sclerosis in Lebanon: A rising prevalence in the middle east
|
Zeineddine, Maya
|
|
|
52 |
C |
p.
|
artikel
|
| 24 |
Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis
|
Allen-Philbey, K.
|
|
|
52 |
C |
p.
|
artikel
|
| 25 |
Immune reconstitution therapy in NMOSD
|
Brod, Staley A.
|
|
|
52 |
C |
p.
|
artikel
|
| 26 |
Improvement over previous decades in time of diagnosis but not in time of initiating DMD in MS patients in Argentina
|
Rojas, Juan I.
|
|
|
52 |
C |
p.
|
artikel
|
| 27 |
Interleukin-1 receptor antagonist: An exploratory plasma biomarker that correlates with disability and provides pathophysiological insights in relapsing-remitting multiple sclerosis
|
Blandford, Stephanie N.
|
|
|
52 |
C |
p.
|
artikel
|
| 28 |
Is there a relationship between anxiety and depression with respiratory functions in patients with relapsing-remitting multiple sclerosis?
|
Eren, Fettah
|
|
|
52 |
C |
p.
|
artikel
|
| 29 |
Lateralization bias for autoimmune optic neuritis
|
Yalachkov, Yavor
|
|
|
52 |
C |
p.
|
artikel
|
| 30 |
Latin American consensus recommendations for management and treatment of neuromyelitis optica spectrum disorders in clinical practice[Mult Scler Relat Disord. 2020 Oct;45:102428]
|
Carnero Contentti, Edgar
|
|
|
52 |
C |
p.
|
artikel
|
| 31 |
Longitudinal analysis of disability outcomes among young people with MS
|
Ow, Nikki
|
|
|
52 |
C |
p.
|
artikel
|
| 32 |
Matching-adjusted indirect treatment comparison of ozanimod versus teriflunomide for relapsing multiple sclerosis
|
Cohan, Stanley
|
|
|
52 |
C |
p.
|
artikel
|
| 33 |
Modified models to distinguish central nervous system demyelinating diseases with brain lesions
|
Chen, Bo
|
|
|
52 |
C |
p.
|
artikel
|
| 34 |
Multiple sclerosis hospitalizations among users of oral disease-modifying therapies
|
Pham Nguyen, Thanh Phuong
|
|
|
52 |
C |
p.
|
artikel
|
| 35 |
Multiple sclerosis-like NMOSD patients suffer severe worsening of status after fingolimod initiation
|
Bonnan, Mickael
|
|
|
52 |
C |
p.
|
artikel
|
| 36 |
Natalizumab differentially affects plasmablasts and B cells in multiple sclerosis
|
Cuculiza Henriksen, Alexander
|
|
|
52 |
C |
p.
|
artikel
|
| 37 |
Natalizumab discontinuation in a Dutch real-world cohort
|
Coerver, E.M.E.
|
|
|
52 |
C |
p.
|
artikel
|
| 38 |
Novel de novo TREX1 mutation in a patient with retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations mimicking demyelinating disease
|
Macaron, Gabrielle
|
|
|
52 |
C |
p.
|
artikel
|
| 39 |
Overlapping syndrome of anti-N-methyl-D-aspartate receptor encephalitis and anti-myelin oligodendrocyte glycoprotein inflammatory demyelinating diseases: A distinct clinical entity?
|
Chen, Weibi
|
|
|
52 |
C |
p.
|
artikel
|
| 40 |
Peripheral blood B cell subset ratios and expression levels of B cell-associated genes are altered in benign multiple sclerosis
|
Turkoglu, Recai
|
|
|
52 |
C |
p.
|
artikel
|
| 41 |
Persons with suspicious onset of multiple sclerosis but with undetermined diagnosis had persistent lower cognition and reduced quality of life
|
Constantinescu, Clara
|
|
|
52 |
C |
p.
|
artikel
|
| 42 |
Polymorphism of the DNA repair gene XDP increases the risk of systemic lupus erythematosus but not multiple sclerosis in the Iranian population
|
Saravani, Mohsen
|
|
|
52 |
C |
p.
|
artikel
|
| 43 |
Positivity of oligoclonal bands in the cerebrospinal fluid predisposed to metabolic changes and rearrangement of inhibitory/excitatory neurotransmitters in subcortical brain structures in multiple sclerosis
|
Kantorová, Ema
|
|
|
52 |
C |
p.
|
artikel
|
| 44 |
Postural stability is a valid and meaningful disability metric in progressive MS with potential for use in neuroprotective therapy trials
|
Yap, Siew Mei
|
|
|
52 |
C |
p.
|
artikel
|
| 45 |
Probing the association between Multiple Sclerosis and Epstein Barr Virus from a therapeutic perspective
|
Drosu, Natalia
|
|
|
52 |
C |
p.
|
artikel
|
| 46 |
Progressive myelopathy in myelin oligodendrocyte glycoprotein antibody-associated disease: A new mimicker of progressive multiple sclerosis?
|
Marcucci, Samuel B.
|
|
|
52 |
C |
p.
|
artikel
|
| 47 |
Reactivation of SARS-CoV-2 after Rituximab in a Patient with Multiple Sclerosis
|
Bose, Gauruv
|
|
|
52 |
C |
p.
|
artikel
|
| 48 |
Registry of patients with multiple sclerosis and COVID-19 infection in Saudi Arabia
|
Alshamrani, Foziah
|
|
|
52 |
C |
p.
|
artikel
|
| 49 |
Sensorimotor function does not predict quality of life in persons with multiple sclerosis
|
Gulde, Philipp
|
|
|
52 |
C |
p.
|
artikel
|
| 50 |
Social cognition in multiple sclerosis and its subtypes: A meta-analysis
|
Lin, XiaoGuang
|
|
|
52 |
C |
p.
|
artikel
|
| 51 |
Socioeconomic status and access to multiple sclerosis treatment in Mexico
|
Gómez-Figueroa, Enrique
|
|
|
52 |
C |
p.
|
artikel
|
| 52 |
Temporal trends in the incidence and prevalence of Multiple Sclerosis in the Northwest of Spain
|
Costa-Arpín, Eva
|
|
|
52 |
C |
p.
|
artikel
|
| 53 |
The course of COVID-19 infection in patients with multiple sclerosis–The experience of one center based on the population of Upper Silesia
|
Nowak-Kiczmer, Maria
|
|
|
52 |
C |
p.
|
artikel
|
| 54 |
The development and impact of cladribine on lymphoid and myeloid cells in multiple sclerosis
|
Voo, Veronica Tsin Fong
|
|
|
52 |
C |
p.
|
artikel
|
| 55 |
The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals?
|
Sen, S.
|
|
|
52 |
C |
p.
|
artikel
|
| 56 |
The trend of incidence, prevalence, and DALY of multiple sclerosis in the Middle East and Northern Africa region compared to global, West Europe and, Iran's corresponding values during 1990–2017: Retrieved from global burden of diseases data
|
Abbastabar, Hedayat
|
|
|
52 |
C |
p.
|
artikel
|
| 57 |
Transcutaneous spinal cord stimulation improves postural stability in individuals with multiple sclerosis
|
Roberts, Brad W.R.
|
|
|
52 |
C |
p.
|
artikel
|
| 58 |
Two cases of myelin oligodendrocyte glycoprotein antibody-associated disease presenting with Cauda Equina Syndrome without conus myelitis
|
Kang, Min sung
|
|
|
52 |
C |
p.
|
artikel
|
| 59 |
18-year temporal trend of multiple sclerosis in southern Iran
|
Mobasheri, Farzaneh
|
|
|
52 |
C |
p.
|
artikel
|
Tijdschrift beschrijving